23/10/2023
ORDER SOON - 077 703 5320
Current or Future Symptoms Against the Effectiveness of Ceylon-Tea-Syrup-Double-Pack (Herbal compounds
Extracts and Ceylon Tea)
The previous and current global influenza (influenza) symptoms, has unfortunately upgraded to XBB in China and later to Eris
subtype in multiple countries, resulted in increased spread of infection with the spike antigen genome, which we suggest was
caused by both genomic types of viral particles in many countries are experiencing severe disease outbreaks. So new-
coronavirus variants are to be expected and will reappear as different severe new strains. Therefore, we guarantee that this is
the only rare discovery that could serve as the world& #39;s first natural intervention suitable for everyone to improve the antiviral
efficacy of previously induced COVID-19 vaccines. Because coronavirus vaccine reactivation is backed by therapeutic efficacy, it
could prevent the spread of virus subtypes that bind to B-cell machinery from person to person, while also helping to prevent
COVID-19 caused by human immune antigen mutants Infecting Cells in the multiple vaccine codes for infectious strains of the
virus are circulating among people in many cities in the world.
Rare treatment for pre-existing COVID vaccines are backed by the world's first international therapy against all current diseases, disorders with virus activation.
Ceylon Vac has demonstrated its extensive benefits in research, with the end result being that it has a regulatory
effect that allows the neutralization of infectious-spike-antigens triggered by Ayurvedic therapies involved with cell-
codes of previously induced COVID-19 mRNA vaccines. With the complete inactivation of infectious viral strains in
the body prevents current viral disease-outbreaks and transmit global-human-to-human virus-strains avoiding rapid
re-infection. The vaccinia-cell-code with a modulatory process that can activate the lipid activity of pre-administered
COVID-19 mRNA vaccines is already inactive as a result of replacing the spike-antigen-protein-component of the
COVID-19 vaccines for the regeneration of antiviral antibody and stimulatory T cell production from previously
induced COVID-19 vaccines in humans with recovery of natural function to defeat invasive infectious antibody T-cells
that cause current infections triggered by humans with infectious virus variants of SARS. CoV-2-coronavirus.
Before Mutagenicity: A Pre-Disaster Control Method Using Vaccine Therapy
The silent transmission of the virus from person to person is the main problem that may arise with the
activation of the first series of DELTA vaccines, where mutations of different risk could reappear due to
the release of the infectious antigen genome into the blood. encoded by vaccines. Particular multi-
Omicron viruses can sometimes reappear and spread around the world, with some clues that may be
understandable from the current global epidemics increasing and causing serious brain infections.
Subsequently, the final integration of the virus strains of the early OMICRON vaccine series and the
DELTA vaccine series may have the possibility of generating new strains with different mutational
subtypes to circulate, which will increase the spread of the virus among themselves, especially affecting
minors injected COVID vaccines in the world and should be monitored them first and evacuated from
people vaccinated against COVID-19. Before differentiating childhood surveillance vaccines from
multiprotein antigen invasion, as a result of viral cross-infections of the same vaccine-borne disease, a
large number of younger generations may become infected due to invasive variants of COVID-19. which
may still be effective in causing serious medical problems with the proliferation of the virus.
